PoliticalRepoPoliticalRepo

United States · Law · HR

H.R. 8900 (116th)

Further Continuing Appropriations Act, 2021, and Other Extensions Act

enactedUnited States· United States Congress· EN

Introduced

8 December 2020

Last action

—

Status

Became Public Law No: 116-215.

Sponsors

—

Subjects

Discovery layer

Source updated

28 May 2025

Official sourceDownload fileView documentsShare

Summary

Further Continuing Appropriations Act, 2021, and Other Extensions Act This bill provides continuing FY2021 appropriations to federal agencies through December 18, 2020, and extends several expiring health programs. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when the existing CR expires on December 11, 2020. The bill includes provisions that extend several public health, Medicare, Medicaid, and Food and Drug Administration authorities and programs; require the Centers for Medicare & Medicaid Services to share Medicare Advantage and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries; and require the Drug Enforcement Administration to revise regulations so as to allow a practitioner to dispense up to a three-day supply of narcotic drugs to one person or for one person's use at one time for the purpose of initiating maintenance treatment or detoxification treatment, or both.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

14 official files

Enrolled Bill (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.